Urinary Tract Infections (UTIs) are uncomfortable, often painful conditions that affect millions of people—especially women.

Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya (pivmecillinam ...

Doctors and scientists are hopeful that the non-antibiotic treatment could ultimately help millions of patients ...

The biggest difference between UTIs and yeast infections? UTIs are caused by bacteria, while yeast infections are caused by a ...

Tired of long waits and rushed appointments? Learn why patients and physicians alike are finding concierge medicine more ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

There’s no magic number for how often a person should have a bowel movement, but if you aren’t going at least three times per week or have trouble passing stool, you might have a form of constipation, ...

Dr. Jason Kim and Dr. Steven Weissbart of the Women’s Pelvic Health and Continence Center at Stony Brook University Hospital ...

Background The KEYNOTE-966 study demonstrated that pembrolizumab combined with chemotherapy is more effective than chemotherapy alone as first-line treatment for patients with advanced biliary tract ...

Geriatrics and Aging. 2008;11(10):582-588. Among the new available antimicrobials, some can be used for UTI treatment ( Table 3). It is to be noted that these drugs have also been approved for ...

Urinary tract infections, or UTIs, are a painful and frustrating problem that many women know all too well. In fact, around half of all women will have a UTI at least once in their lives. For some ...

Fecal Transplant Potential First-Line Treatment For C. Difficile Infection Jun 20, 2025 Updated Jun 20, 2025 ...